CFGI Promotes New Partners for 2021
We are excited to announce our newly promoted CFGI Partners.
Meet Robert Keep: CFGI’s Boston Office Leader and Accounting Advisory Expert
CFGI’s Robert Keep may be English by birth, but he’s a Bostonian through and through.
Olema Pharmaceuticals Closes $209 Million Initial Public Offering with Support from CFGI
CFGI’s Capital Markets team supported Olema Pharmaceuticals (Nasdaq: OLMA) with an initial public offering of 11,000,000 shares of common stock priced at $19.
Matt Estadt Jumpstarts CFGI’s Transaction Advisory Services
If you want to succeed in the transaction services field, you need to stand out.
FASB simplifies issuer’s accounting for certain debt and equity instruments through the elimination of the ‘beneficial conversion feature’ and ‘cash conversion feature’ separation models and changes to equity classification criteria
Summary The FASB has simplified the accounting for convertible debt and equity instruments and contracts issued in an entity’s own equity with the issuance of ASU 2020-06.
Vital Farms Closes $111 Million Initial Public Offering with Support from CFGI
CFGI’s Capital Markets team supported Vital Farms (Nasdaq: VITL) with an initial public offering of 5,040,323 shares of common stock priced at $22.